ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 112 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $701,660 | -35.1% | 102,434 | -1.8% | 0.00% | 0.0% |
| Q2 2023 | $1,081,870 | +152276.1% | 104,327 | +18.9% | 0.00% | 0.0% |
| Q1 2023 | $710 | -47.5% | 87,756 | +2.2% | 0.00% | -50.0% |
| Q4 2022 | $1,352 | -99.9% | 85,862 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $1,314,000 | +30.7% | 83,492 | +16.0% | 0.00% | +100.0% |
| Q2 2022 | $1,005,000 | +5.6% | 71,999 | +30.4% | 0.00% | 0.0% |
| Q1 2022 | $952,000 | +40.2% | 55,194 | +18.1% | 0.00% | 0.0% |
| Q4 2021 | $679,000 | -16.7% | 46,725 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $815,000 | +10.9% | 45,301 | +8.2% | 0.00% | 0.0% |
| Q2 2021 | $735,000 | +1261.1% | 41,866 | -18.9% | 0.00% | – |
| Q1 2020 | $54,000 | -49.1% | 51,626 | -7.8% | 0.00% | – |
| Q4 2019 | $106,000 | +82.8% | 55,994 | +3.6% | 0.00% | – |
| Q3 2019 | $58,000 | -46.8% | 54,059 | +8.3% | 0.00% | – |
| Q2 2019 | $109,000 | -60.4% | 49,895 | +8.6% | 0.00% | -100.0% |
| Q1 2019 | $275,000 | -5.8% | 45,962 | +16.4% | 0.00% | 0.0% |
| Q4 2018 | $292,000 | -23.4% | 39,490 | +50.6% | 0.00% | 0.0% |
| Q3 2018 | $381,000 | -29.7% | 26,221 | -3.3% | 0.00% | 0.0% |
| Q2 2018 | $542,000 | +39.3% | 27,126 | +22.3% | 0.00% | 0.0% |
| Q1 2018 | $389,000 | -28.6% | 22,183 | +0.4% | 0.00% | 0.0% |
| Q4 2017 | $545,000 | -12.2% | 22,093 | -8.1% | 0.00% | 0.0% |
| Q3 2017 | $621,000 | -0.2% | 24,048 | +4.8% | 0.00% | 0.0% |
| Q2 2017 | $622,000 | +78.2% | 22,953 | +96.4% | 0.00% | 0.0% |
| Q1 2017 | $349,000 | +26.9% | 11,687 | +15.3% | 0.00% | 0.0% |
| Q4 2016 | $275,000 | +31.0% | 10,132 | +23.7% | 0.00% | 0.0% |
| Q3 2016 | $210,000 | – | 8,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |